| 1 |
Schiff D, Van den Bent M, Vogelbaum MA, et al. Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus [J]. Neuro Oncol, 2019, 21(7): 837-853.
|
| 2 |
GBD 2016 Brain and Other CNS Cancer Collaborators. Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 [J]. Lancet Neurol, 2019, 18(4): 376-393.
|
| 3 |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| 4 |
Wang X, Chen JX, Zhou Q, et al. Statistical report of central nervous system tumors histologically diagnosed in the Sichuan province of China from 2008 to 2013: A west China glioma center report [J]. Ann Surg Oncol, 2016, 23(Suppl 5): 946-953.
|
| 5 |
Saito T, Sugiyama K, Takeshima Y, et al. Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide [J]. J Neurosurg, 2018, 128(3): 679-684.
|
| 6 |
Wang L, Lu M, Zhang R, et al. Inhibition of Luman/CREB3 expression leads to the upregulation of testosterone synthesis in mouse Leydig cells [J]. J Cell Physiol, 2019, 234(9): 15257-15269.
|
| 7 |
Xue H, Zhang J, Guo X, et al. CREBRF is a potent tumor suppressor of glioblastoma by blocking hypoxia-induced autophagy via the CREB3/ATG5 pathway [J]. Int J Oncol, 2016, 49(2): 519-528.
|
| 8 |
Hu Y, Chu L, Liu J, et al. Knockdown of CREB3 activates endoplasmic reticulum stress and induces apoptosis in glioblastoma [J]. Aging (Albany NY), 2019, 11(19): 8156-8168.
|
| 9 |
Demircioglu F, Wang J, Candido J, et al. Cancer associated fibroblast FAK regulates malignant cell metabolism [J]. Nat Commun, 2020, 11(1): 1290.
|
| 10 |
Wu HJ, Hao M, Yeo SK, et al. FAK signaling in cancer-associated fibroblasts promotes breast cancer cell migration and metastasis by exosomal miRNAs-mediated intercellular communication [J]. Oncogene, 2020, 39(12): 2539-2549.
|
| 11 |
Mitra SK, Schlaepfer DD. Integrin-regulated FAK-Src signaling in normal and cancer cells [J]. Curr Opin Cell Biol, 2006, 18(5): 516-523.
|
| 12 |
Wang X, Fu X, Zhao S, et al. Antiangiogenic properties of caudatin in vitro and in vivo by suppression of VEGF-VEGFR2-AKT/FAK signal axis [J]. Mol Med Rep, 2017, 16(6): 8937-8943.
|
| 13 |
Wang J, Cai C, Nie D, et al. FRK suppresses human glioma growth by inhibiting ITGB1/FAK signaling [J]. Biochem Biophys Res Commun, 2019, 517(4): 588-595.
|
| 14 |
Furnari FB, Cloughesy TF, Cavenee WK, et al. Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma [J]. Nat Rev Cancer, 2015, 15(5): 302-310.
|
| 15 |
Wen PY, Reardon DA. Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatment [J]. Nat Rev Neurol, 2016, 12(2): 69-70.
|
| 16 |
Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma [J]. N Engl J Med, 2005, 352(10): 987-996.
|
| 17 |
Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways [J]. Nature, 2008, 455(7216): 1061-1068.
|
| 18 |
Fox RM, Hanlon CD, Andrew DJ. The CrebA/Creb3-like transcription factors are major and direct regulators of secretory capacity [J]. J Cell Biol, 2010, 191(3): 479-492.
|
| 19 |
Ying Z, Zhang R, Verge VM, et al. Cloning and characterization of rat Luman/CREB3, a transcription factor highly expressed in nervous system tissue [J]. J Mol Neurosci, 2015, 55(2): 347-354.
|
| 20 |
Cao G, Ni X, Jiang M, et al. Molecular cloning and characterization of a novel human cAMP response element-binding (CREB) gene (CREB4) [J]. J Hum Genet, 2002, 47(7): 373-376.
|
| 21 |
Xue H, Zhang J, Guo X, et al. CREBRF is a potent tumor suppressor of glioblastoma by blocking hypoxia-induced autophagy via the CREB3/ATG5 pathway [J]. Int J Oncol, 2016, 49(2): 519-528.
|
| 22 |
Lee BY, Timpson P, Horvath LG, et al. FAK signaling in human cancer as a target for therapeutics [J]. Pharmacol Ther, 2015, 146: 132-149.
|
| 23 |
Lechertier T, Hodivala-Dilke K. Focal adhesion kinase and tumour angiogenesis [J]. J Pathol, 2012, 226(2): 404-412.
|
| 24 |
Zheng KB, Xie J, Li YT, et al. Knockdown of CERB expression inhibits proliferation and migration of glioma cells line U251 [J]. Bratisl Lek Listy, 2019, 120(4): 309-315.
|
| 25 |
Avizienyte E, Frame MC. Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition [J]. Curr Opin Cell Biol, 2005, 17(5): 542-547.
|
| 26 |
Gabarra-Niecko V, Schaller MD, Dunty JM. FAK regulates biological processes important for the pathogenesis of cancer [J]. Cancer Metastasis Rev, 2003, 22(4): 359-374.
|
| 27 |
Wörthmüller J, Blum W, Pecze L, et al. Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway [J]. Oncotarget, 2018, 9(91): 36256-36272.
|